Thomas Hudson
Chief Tech/Sci/R&D Officer presso ABBVIE INC.
Patrimonio netto: 20 M $ in data 31/03/2024
Profilo
Fondatore della McGill University e dello Gnome Qubec Innovation Centre, Thomas J. Hudson è Chief Scientific Officer, Senior VP-R&D presso AbbVie, Inc. È anche direttore scientifico del P3G Consortium e professore all'Università di Toronto. In passato è stato presidente e direttore scientifico all'Ontario Institute for Cancer Research, assistente direttore del centro di ricerca sul genoma al Whitehead Institute for Biomedical Research e direttore della McGill University & Gnome Qubec Innovation Centre.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ABBVIE, INC.
0.01% | 28/02/2024 | 107 267 ( 0.01% ) | 20 M $ | 31/03/2024 |
Posizioni attive di Thomas Hudson
| Società | Posizione | Inizio |
|---|---|---|
| ABBVIE INC. | Chief Tech/Sci/R&D Officer | 01/07/2019 |
| University of Toronto | Corporate Officer/Principal | 01/01/2007 |
| P3G Consortium | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Thomas Hudson
| Società | Posizione | Fine |
|---|---|---|
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | President | 01/01/2016 |
| McGill University & Génome Québec Innovation Centre | Founder | 01/01/2011 |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2001 |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Formazione di Thomas Hudson
| University of Montréal | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
| P3G Consortium |
- Borsa valori
- Insiders
- Thomas Hudson
